Dow Jones

42,342.24

0.04%

Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

Regístrate

Inicio
Invertir
Acciones
Estados Unidos
NASDAQ
Assembly Biosciences Inc (ASMB)
Assembly Biosciences Inc (ASMB) Noticias

ASMB

Assembly Biosciences (ASMB)

Assembly Biosciences Inc

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:ASMB

1 2 3 4 5 6 7 8 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
19/12/2024	07:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ASMB	Assembly Biosciences Inc
19/12/2024	07:00	GlobeNewswire Inc.	Assembly Biosciences Announces $30.1 Million Equity Investment and Accelerated Funding from Gilead to Advance Clinical Development Programs	NASDAQ:ASMB	Assembly Biosciences Inc
26/11/2024	08:15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ASMB	Assembly Biosciences Inc
14/11/2024	14:22	Edgar (US Regulatory)	Form SC 13G - Statement of Beneficial Ownership by Certain Investors	NASDAQ:ASMB	Assembly Biosciences Inc
07/11/2024	15:42	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:ASMB	Assembly Biosciences Inc
07/11/2024	15:24	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:ASMB	Assembly Biosciences Inc
07/11/2024	15:05	GlobeNewswire Inc.	Assembly Biosciences Reports Third Quarter 2024 Financial Results and Recent Updates	NASDAQ:ASMB	Assembly Biosciences Inc
23/09/2024	07:00	GlobeNewswire Inc.	Assembly Biosciences Reports Positive Interim Phase 1a Results from Clinical Trial Evaluating Long-Acting Helicase-Primase Inhibitor Candidate ABI-5366	NASDAQ:ASMB	Assembly Biosciences Inc
08/08/2024	15:31	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:ASMB	Assembly Biosciences Inc
08/08/2024	15:05	GlobeNewswire Inc.	Assembly Biosciences Reports Second Quarter 2024 Financial Results and Recent Updates	NASDAQ:ASMB	Assembly Biosciences Inc
15/07/2024	07:00	GlobeNewswire Inc.	Assembly Biosciences Presents New Preclinical Data Highlighting Investigational Helicase-Primase Inhibitors at International Herpesvirus Workshop	NASDAQ:ASMB	Assembly Biosciences Inc
18/06/2024	07:00	GlobeNewswire Inc.	Assembly Biosciences Doses First Participant in Phase 1b Clinical Trial Evaluating Next-Generation Capsid Assembly Modulator Candidate ABI-4334 for the Treatment of Chronic Hepatitis B Virus Infection	NASDAQ:ASMB	Assembly Biosciences Inc
17/06/2024	07:00	GlobeNewswire Inc.	Assembly Biosciences Announces $12.6 Million in Equity Financings	NASDAQ:ASMB	Assembly Biosciences Inc
10/06/2024	07:00	GlobeNewswire Inc.	Assembly Biosciences Doses First Participant in Phase 1a/b Clinical Trial of Herpes Simplex Virus Helicase-Primase Inhibitor Candidate ABI-5366	NASDAQ:ASMB	Assembly Biosciences Inc
05/06/2024	07:00	GlobeNewswire Inc.	Assembly Biosciences Presents New Data Highlighting Hepatitis D Virus Entry Inhibitor ABI-6250 at the EASL Congress™ 2024	NASDAQ:ASMB	Assembly Biosciences Inc
22/05/2024	07:00	GlobeNewswire Inc.	Assembly Biosciences to Present Data at Upcoming International Herpesvirus Workshop and EASL Congress™ 2024	NASDAQ:ASMB	Assembly Biosciences Inc
08/05/2024	15:05	GlobeNewswire Inc.	Assembly Biosciences Reports First Quarter 2024 Financial Results and Recent Highlights	NASDAQ:ASMB	Assembly Biosciences Inc
28/03/2024	15:05	GlobeNewswire Inc.	Assembly Biosciences Reports Fourth Quarter and Year End 2023 Financial Results and Recent Highlights	NASDAQ:ASMB	Assembly Biosciences Inc
08/02/2024	07:00	GlobeNewswire Inc.	Assembly Biosciences Announces Effective Date of Reverse Stock Split	NASDAQ:ASMB	Assembly Biosciences Inc
04/01/2024	07:00	GlobeNewswire Inc.	Assembly Biosciences Provides Anticipated Development Milestones for 2024	NASDAQ:ASMB	Assembly Biosciences Inc
21/12/2023	15:06	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:ASMB	Assembly Biosciences Inc
21/12/2023	15:01	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:ASMB	Assembly Biosciences Inc
11/12/2023	15:10	Edgar (US Regulatory)	Form PRE 14A - Other preliminary proxy statements	NASDAQ:ASMB	Assembly Biosciences Inc
11/12/2023	15:05	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:ASMB	Assembly Biosciences Inc
22/11/2023	15:12	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:ASMB	Assembly Biosciences Inc
10/11/2023	15:05	GlobeNewswire Inc.	Assembly Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:ASMB	Assembly Biosciences Inc
10/11/2023	07:00	GlobeNewswire Inc.	Assembly Biosciences Presents New Data Highlighting Viral Hepatitis Portfolio at AASLD The Liver Meeting®	NASDAQ:ASMB	Assembly Biosciences Inc
08/11/2023	15:05	GlobeNewswire Inc.	Assembly Biosciences Reports Third Quarter 2023 Financial Results and Recent Updates	NASDAQ:ASMB	Assembly Biosciences Inc
08/11/2023	07:00	GlobeNewswire Inc.	Assembly Biosciences Names Anuj Gaggar, MD, PhD, as Chief Medical Officer	NASDAQ:ASMB	Assembly Biosciences Inc
31/10/2023	15:19	Edgar (US Regulatory)	Form SC 13D - General statement of acquisition of beneficial ownership	NASDAQ:ASMB	Assembly Biosciences Inc